Public Library of Science

SHERPA: Unknown

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Heelan
    Heelan
  4. Ladanyi
    Ladanyi

Groups

  1. Department of Medicine (2)
  2. Department of Pathology and Laboratory Medicine (2)
  3. Solid Tumor Oncology Division (2)
  4. Thoracic Oncology (2)
  5. GSK Faculty (1)
  6. Human Oncology and Pathogenesis Program (1)
  7. Sloan Kettering Institute Postdocs (1)
  8. Tow Center for Developmental Oncology (TCDO) (1)
Search Within
  1. "Maureen Zakowski"
Formats
  1. Journal Article (2)
Groups
  1. Department of Medicine (2)
  2. Department of Pathology and Laboratory Medicine (2)
  3. Solid Tumor Oncology Division (2)
  4. Thoracic Oncology (2)
  5. GSK Faculty (1)
  6. Human Oncology and Pathogenesis Program (1)

More Groups

People
  1. Gregory Riely (2)
  2. Harold Varmus (2)
  3. Mark Kris (2)
  4. Maureen Zakowski (2)
  5. Vincent Miller (2)
  6. William Pao (2)

More People

Years
  1. 2005 (2)
Publications
  1. PLos Medicine (2)

Results (2)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
    Journal Article

    Pao, W.; Wang, T. Y.; Riely, G. J.; Miller, V. A.; Pan, Q.; Ladanyi, M.; Zakowski, M. F.; Heelan, R. T.; Kris, M. G.; Varmus, H. E.
    PLos Medicine (2005)

    Fulltext@MSK | Save
  • Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
    Journal Article

    Pao, W.; Miller, V. A.; Politi, K. A.; Riely, G. J.; Somwar, R.; Zakowski, M. F.; Kris, M. G.; Varmus, H.
    PLos Medicine (2005)

    Fulltext@MSK | Save

    • Public Library of Science – authorized name for: